LIM Domain 7 (LMO7) Peptide
LMO7
Reactivité: Humain
Hôte: Synthetic
BP, BI
N° du produit ABIN5685242
Aperçu rapide pour LIM Domain 7 (LMO7) Peptide (ABIN5685242)
Antigène
LMO7
(LIM Domain 7 (LMO7))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), BioImaging (BI)
-
-
Attributs du produit
- LMO7 peptide corresponds to 12 amino acids of LMO7.
-
-
-
-
Indications d'application
- LMO7 Peptide is used for blocking the activity of LMO7 antibody . The LMO7 antibody ships at 0.5 mg/mL and the LMO7 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- LMO7 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
- LMO7 (LIM Domain 7 (LMO7))
-
ID gène
- 4008
-
OMIM
- 4929268
-
UniProt
- Q8WWI1
Antigène
-
Vous êtes ici:
